This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches

Read more

  • Cooperation studies on inherited susceptibility to colorectal cancer
  • Graphic




October 05-06, 2020

Working Group 1 meeting

This meeting will focus on Disease risk profiling (WG1). It will not include a Management Committee meeting. It could take place ONLINE due to the current circumstances.

More about "Working Group 1 meeting"



October 30-31, 2020

Annual Congress of Liquid Biopsy. ISLB

This congress is organized by some participants of our COST Action (María José Serrano, Juan José Díaz, Carmen Garrido, José Antonio Lorente) and we are disseminating it to other participants in case they may be interested.

More about "Annual Congress of Liquid Biopsy. ISLB"


Video series on gut health

Wednesday, 12 August 2020

Godfrey Grech, associate professor of pathology at the University of Malta and TRANSCOLONCAN member, has established an educational YouTube channel on gut health.

More about "Video series on gut health"

COST is supported by the EU Framework Programme Horizon 2020